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A B S T R A C T
Background
Falls are one of the most common medical complications after stroke with a reported incidence of 7% in the first week after stroke
onset. Studies investigating falls in the later phase after stroke report an incidence of up to 73% in the first year post-stroke.
Objectives
To evaluate the effectiveness of interventions aimed at preventing falls in people after stroke.
Search methods
We searched the trials registers of the Cochrane Stroke Group (November 2012) and the Cochrane Bone, Joint and Muscle Trauma
Group (May 2012), theCochrane Central Register of ControlledTrials (CENTRAL) inThe Cochrane Library 2012, Issue 5,MEDLINE
(1950 to May 2012), EMBASE (1980 to May 2012), CINAHL (1982 to May 2012), PsycINFO (1806 to May 2012), AMED (1985
to May 2012) and PEDro (May 2012). We also searched trials registers, checked reference lists and contacted authors.
Selection criteria
Randomised controlled trials of interventions where the primary or secondary aim was to prevent falls in people after stroke.
Data collection and analysis
Review authors independently selected studies for inclusion, assessed trial quality, and extracted data. We used a rate ratio and 95%
confidence interval (CI) to compare the rate of falls (e.g. falls per person year) between intervention and control groups. For risk
of falling we used a risk ratio and 95% CI based on the number of people falling (fallers) in each group. We pooled results where
appropriate.
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Main results
We included 10 studies with a total of 1004 participants. One study evaluated the effect of exercises in the acute and subacute phase
after stroke but found no significant difference in rate of falls (rate ratio 0.92, 95% CI 0.45 to 1.90, 95 participants). The pooled result
of four studies investigating the effect of exercises on preventing falls in the chronic phase also found no significant difference for rate
of falls (rate ratio 0.75, 95% CI 0.41 to 1.38, 412 participants).
For number of fallers, one study examined the effect of exercises in the acute and subacute phase after stroke but found no significant
difference between the intervention and control group (risk ratio 1.19, 95% CI 0.83 to 1.71, 95 participants). The pooled result of
six studies examining the effect of exercises in the chronic phase also found no significant difference in number of fallers between the
intervention and control groups (risk ratio 1.02, 95% CI 0.83 to 1.24, 616 participants).
The rate of falls and the number of fallers was significantly reduced in two studies evaluating the effect of medication on preventing
falls; one study (85 participants) compared vitamin D versus placebo in institutionalised women after stroke with low vitamin D levels,
and the other study (79 participants) evaluated alendronate versus alphacalcidol in hospitalised people after stroke.
One study provided single lens distance glasses to regular wearers of multifocal glasses. In a subgroup of 46 participants post-stroke
there was no significant difference in the rate of falls (rate ratio 1.08, 95% CI 0.52 to 2.25) or the number of fallers between both
groups (risk ratio 0.74, 95% CI 0.47 to 1.18).
Authors’ conclusions
There is currently insufficient evidence that exercises or prescription of single lens glasses to multifocal users prevent falls or decrease
the number of people falling after being discharged from rehabilitation following their stroke. Two studies testing vitamin D versus
placebo and alendronate versus alphacalcidol found a significant reduction in falls and the number of people falling. However, these
findings should be replicated before the results are implemented in clinical practice.
P L A I N L A N G U A G E S U M M A R Y
Interventions for preventing falls in people after stroke
Falls are commonly seen in people who have had a stroke and occur in 7% of people in the first week after their stroke. In the later
phase after stroke, 55% to 73% of people experience a fall one year after their stroke. Not all falls are serious enough to require medical
attention but even non-serious falls may lead to people developing a fear of falling. They are a factor for predicting future falls, which
may restrict the person’s activities of daily living and therefore require attention. This review investigated which methods are effective
for preventing falls in people after their stroke. After searching the literature, we included 10 studies with a total of 1004 participants.
We found studies that investigated exercises, medication, and the provision of single lens distance vision glasses instead of multifocal
glasses for preventing falls. Exercises did not appear to reduce the rate of falls or the number of people falling. The majority of studies
asked participants to do exercises only. One study offered exercises together with additional components such as educational sessions
about falls. Another study offered exercises together with a comprehensive risk assessment and subsequent referrals, such as a review by
an optometrist or new shoes, leading to a personalised programme for preventing falls. Neither of these two studies reduced the rate of
falls or the number of people falling. One study, which gave vitamin D to women after their stroke who had low vitamin D levels and
were admitted to long-term care, showed a reduction in the rate of falls and the number of people falling. In another study, alendronate
led to a reduction in the rate of falls and the number of people falling in people hospitalised after their stroke. More studies of this kind
should be done to confirm these findings before the results are implemented into clinical practice. There is no evidence at the moment
that single lens distance vision glasses instead of multifocal glasses reduce the rate of falls or the number of people falling. In summary,
there is little evidence that interventions for preventing falls in people after stroke are beneficial. The main reason is that there were
only a limited number of studies focusing on people after stroke or that included a stroke subgroup in the study. More research in this
important area for people after stroke is therefore warranted.
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B A C K G R O U N D
Description of the condition
Falls are one of the most common medical complications after
stroke (Davenport 1996; Langhorne 2000). A recent study includ-
ing fall events early after stroke showed an incidence of 7% in the
first week after stroke onset (Indredavik 2008). Incidence figures
from studies collecting data between one and six months post-
stroke vary from 25% (Indredavik 2008) to 37% (Kerse 2008).
Studies evaluating participants between six and 12 months after
stroke report incidences from 40% (Belgen 2006) to 50% (Harris
2005). One year after stroke, the reported incidence ranges from
55% (Ashburn 2008) to 73% (Sackley 2008). Not all falls are seri-
ous enough to require medical attention, but non-serious falls are
a known predictor for future falls, and can lead to fear of falling,
and may restrict a person’s activities of daily living. In summary,
serious and non-serious falls are still among the most common
complications after stroke and their increasing incidence poses a
challenge for rehabilitation.
Many stroke-related impairments contribute to deficits of balance
and falls, e.g. muscle weakness, sensory loss, reduced attention,
and abnormalities of vision and spatial awareness (Weerdesteyn
2008). A fall is a strongpredictor of further falls amongpeoplewith
stroke living in the community. However, all people with residual
difficulties following a stroke should be considered at increased
risk (Ashburn 2008).
Description of the intervention
Few researchers have examined fall prevention or management
post-stroke, but interventions recommended for the general el-
derly population who have experienced falls have been utilised.
Preliminary evidence shows that task-specific exercise programmes
targeting balance and gait deficits can be beneficial, can reduce
fall frequency and are thought to drive neural plasticity (Shepherd
2001). Technological advances in assistive devices, such as ankle-
foot orthosis, walking aids (Kuan 1999) and functional electrical
stimulation (Burridge 2007) have also been shown to produce ev-
idence of improved mobility, although the benefits with respect to
falls prevention in people who have had a stroke still need to be
evaluated in intervention studies (Weerdesteyn 2008).
Why it is important to do this review
A summary of the evidence is important for informing evidence-
based practice, and to identify gaps in research. There are exist-
ing reviews on the prevention of falls for older people (Cameron
2012; Gillespie 2012). However, a stroke is a serious condition
leading to altered physical, cognitive and psychological impair-
ments specifically related to the problemof falls in this population.
In addition, persistent impairments in the later stages after stroke
can contribute to the increasing incidence of falls in people after
stroke. It is currently very unclear how much research has been
dedicated to examining the effect of interventions specific to falls
in connection with stroke. This review therefore focuses specifi-
cally on interventions for preventing falls in people after stroke.
O B J E C T I V E S
To evaluate the effectiveness of interventions aimed at preventing
falls in people after stroke.Our primary objective was to determine
the effect of interventions on the rate of falls (number of falls
divided by length of follow-up) and the number of fallers. Our
secondary objectives were to determine the effects of interventions
aimed at preventing falls on (1) the number of fall-related fractures,
(2) the number of fall-related hospital admissions, (3) near-fall
events, (4) economic evaluation, (5) quality of life, and (6) adverse
effects of the interventions.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included controlled trials where participants or clusters were
randomly allocated. Had any cross-over trials met our inclusion
criteria, we would have included the first phase if the order of
assignment was determined randomly.
Types of participants
We included trials with adult participants (over 18 years of age) in
the acute, subacute or chronic stage following stroke with a con-
firmed diagnosis. Diagnosis of stroke comprised ischaemic as well
as haemorrhagic events. People in the acute stage after stroke were
defined as people admitted to a dedicated stroke unit or acute hos-
pital ward. People in the subacute stage after stroke were people
admitted to a rehabilitation ward or clinic after being discharged
from an acute ward, or people who received intensive treatment at
home, for example early supported discharge. Finally, we defined
people in the chronic stage after stroke as people who were dis-
charged from rehabilitation and were living at home or admitted
to institutional care.
We included trials reporting an intervention carried out in amixed
sample of participants, including people after stroke, if data were
provided separately (i.e. in a subgroup) for people after stroke.
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Types of interventions
We included any intervention where a stated primary or secondary
aim was to prevent falls. We classified the interventions according
to the taxonomy developed by the Prevention of Falls Network
Europe (ProFaNE) (Lamb 2007; Lamb 2011), which proposes the
following categories.
• Exercises (supervised/unsupervised): including gait, balance
and functional training; strength/resistance exercises; flexibility
exercises (e.g. yoga); 3D training (e.g. Tai Chi, Qi Gong);
general physical activity; endurance training or others.
• Medication (drug target): direct action targeted to specific
classes of drugs: including antihypertensives, other cardiovascular
agents, vitamin D, calcium, other bone health medication, drugs
used in diabetes, anti-Parkinson drugs, anti-dementia drugs,
antidepressants, antipsychotic/neuroleptic drugs, anxiolytics,
hypnotics and sedatives, other central nervous system drugs,
urinary antispasmodics or other specified drugs.
• Surgery: including cataract extraction, pacemaker
provision, podiatric surgery or intervention, or others.
• Management of urinary incontinence (e.g. assisted
toileting, bladder retraining).
• Fluid or nutrition therapy where the basic objective was to
restore the volume and composition of the body fluids to normal
with respect to water-electrolyte balance (fluid therapy) or to
improve the health status of the individual by adjusting the
quantities, qualities, and methods of nutrient intake (nutrition
therapy).
• Psychological intervention, either individual or in a group,
including cognitive (behavioural) intervention, or others.
• Environment/assistive technology, which includes technical
aids for people with disabilities.
◦ Environment (furnishings and adaptations to homes
and other premises): direct action including dwelling unit
indoors (including entrances), dwelling unit outdoors, public
outdoor (e.g. pavement) or relocation.
◦ Environment (aids for personal mobility such as
walking aid, wheelchair).
◦ Environment (aids for communication, information
and signalling): including optical aids, hearing aids, aids for
signalling and indicating or alarm systems.
◦ Environment (body-worn aids for personal care and
protection): including body-worn protective aids, clothes and
shoes, or others.
• Environmental (social environment): including staff ratio,
staff training, service model change, telephone support, caregiver
training, homecare services, or others.
• Knowledge interventions: including written material,
videos, lectures or others.
• Other interventions/procedures.
We classified interventions into single interventionswith one com-
ponent; multiple interventions with more than one component,
but the intervention was the same for all participants; and multi-
factorial interventions with more than one component and the in-
terventionmodified for every participant personally (Lamb 2007).
We compared the intervention for preventing falls with no addi-
tional treatment (routine care) or with another type of interven-
tion.
Types of outcome measures
We included only those trials that reported an outcome measure
related to the rate of falls or the number of fallers. We included
trials where falls were collected either prospectively or retrospec-
tively. We expected to find different definitions of a fall, although
a consensus report (Lamb 2005) recommends that a fall should be
defined as “an unexpected event in which the participants come
to rest on the ground, oor, or lower level.”
Primary outcomes
• Rate of falls.
• Number of fallers.
Secondary outcomes
• Number of people sustaining fall-related fractures.
• Number of people with fall-related hospital admissions.
• Number of people with near-fall events (typically defined as
an occasion on which a person felt that they were about to fall,
but did not actually fall) (Stack 1999).
• Economic evaluation.
• Quality of life (including psychological aspects such as fear
of falling).
• Adverse events.
Search methods for identification of studies
See the ’Specialized register’ section in the Cochrane Stroke Group
module. We searched for reports of relevant trials in all languages.
We did not include studies published only in abstract form.
Electronic searches
We searched the trials registers of the Cochrane Stroke Group
(last searched November 2012) and the Cochrane Bone, Joint
and Muscle Trauma Group (last searched May 2012). In addi-
tion, we searched: the Cochrane Central Register of Controlled
Trials (CENTRAL) in The Cochrane Library 2012, Issue 5, MED-
LINE (1950 toMay 2012) (Appendix 1), EMBASE (1980 toMay
2012) (Appendix 2), CINAHL (1982 toMay 2012) (Appendix 3),
PsycINFO (1806 to May 2012) (Appendix 4), AMED (1985 to
May 2012) (Appendix 5), and Physiotherapy Evidence Database
(PEDro) (www.pedro.org.au/) (May 2012).
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We developed the MEDLINE search strategy with the help of the
Cochrane Stroke Group Trials Search Co-ordinator and adapted
it for the other databases.
We also searched the followingongoing trials registers (May 2012):
ClinicalTrials.gov (http://clinicaltrials.gov/), Current Controlled
Trials (www.controlled-trials.com/), International Clinical Trials
Registry PlatformSearch Portal (http://apps.who.int/trialsearch/),
and Stroke Trials Registry (www.strokecenter.org/trials/).
Searching other resources
In an effort to identify further published, ongoing and planned
trials we:
• checked reference lists of relevant articles;
• contacted trialists and researchers in the field;
• used Science Citation Index Cited Reference Search for
forward tracking of important articles.
Data collection and analysis
Selection of studies
Two review authors (GV and VW) independently screened the
titles, abstracts and descriptors of the records obtained from the
electronic searches and excluded obviously irrelevant studies. We
obtained the full text of the remaining studies and four authors
(GV, VW, SL, and AA) independently assessed these for inclusion
based on the review eligibility criteria. We resolved disagreements
through discussion and contacted study authors for additional
information where required.
Data extraction and management
Three review authors (GV, VW and SL) independently extracted
data on to a pre-tested data extraction sheet. We resolved disagree-
ments through discussion, together with the statistical expert (RP).
Assessment of risk of bias in included studies
Three review authors (GV, VW and SL) independently assessed
risk of bias for the following items of each included trial (Higgins
2011a): sequence generation (randomisation), allocation conceal-
ment, blinding of assessors (for falls) and incomplete outcome data
and selective outcome reporting. We included one additional risk
of bias item: reliable ascertainment of fall/fallers outcome where
’low risk of bias’ means ascertainment of outcome via active reg-
istration, e.g. falls diary; ’high risk of bias’ if ascertainment relied
on participants’ recall over a longer period of time (more than one
month); and ’unclear risk of bias’ if ascertainment relied on par-
ticipants’ recall over a short period of time (one month or less) or
if method of ascertainment was not described.
We collected this information on the data extraction sheet and
resolved disagreements through discussion.
Measures of treatment effect
We used results reported at one year if these were available for
trials that monitored falls for longer than one year, and carried out
separate analyses pooling information on rates of falling, and risks
of falling once or more within a set time period (preferably a year),
following the analyses carried out by Gillespie 2012.
We used the generic inverse variance method for pooling rate and
risk ratios, which were entered according to the information avail-
able in the source papers, and we set the software to display results
in the original scale. We obtained standard errors of the logarithm
of the intervention effect using the method described in section
7.7.7.3 of the Cochrane Handbook when a properly estimated
confidence interval for the intervention effect was presented in the
study report. We included properly analysed unadjusted interven-
tion effects if they were available; otherwise, we considered incor-
porating properly analysed adjusted estimates of effect, or calcu-
lated estimates of unadjusted effects depending on the validity of
obtaining estimates from the information presented in the source
report (see Unit of analysis issues). Where necessary, we calculated
rate ratio estimates of treatment effect using the method described
in section 9.4.8 of the Cochrane Handbook and calculated risk
ratios using the methods described in section 9.2.2.
The above analysis was based on that carried out in the Cochrane
review of interventions for preventing falls in older people living
in the community (Gillespie 2012), and so we anticipated that the
same analysis would be appropriate when restricted to studies in
people after stroke.
For our secondary outcomes (number of people sustaining fall-
related fractures, number of people with fall-related hospital ad-
missions, number of people with near-fall events, economic evalu-
ation, quality of life and adverse events), we expected limited and
heterogeneous results throughout the included studies. We there-
fore provided a narrative description of these results.
Unit of analysis issues
We planned to incorporate any cluster-randomised trials that we
found according to the advice in the Cochrane Handbook, section
16.3, and any cross-over trials according to section 16.4.
Dealing with missing data
We contacted study authors to acquire missing data. We planned
a sensitivity analysis for studies with missing data (see Sensitivity
analysis) but were unable to include this because of the limited
number of included studies.
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Assessment of heterogeneity
We assessed heterogeneity visually by means of forest plots and by
reporting the I² statistic (Higgins 2003). We carried out analyses
of subgroups of studies (in the acute/subacute and chronic phase
after stroke) in an attempt to explain heterogeneity by study char-
acteristics. As our search resulted in heterogeneous trials that pro-
vided information which could be pooled, we conducted a ran-
dom-effects meta-analysis incorporating random heterogeneity in
intervention effect across studies into the standard error of the
effect size, so that our findings can be generalised more widely.
Assessment of reporting biases
We discuss possible problems in the Discussion section of our
review. We minimised reporting bias by using a comprehensive
search strategy, by searching for studies in other languages than
English, and by searching the grey literature (see Searching other
resources).
Data synthesis
Since the studies we found were of a heterogeneous nature, we
performed random-effects meta-analyses in all cases. We pooled
results from comparable single, multiple and multifactorial inter-
ventions as defined in the Types of interventions section above and
as presented in the Results section below.
Subgroup analysis and investigation of heterogeneity
Based on the results of our review, we presented the effect of in-
terventions for preventing falls in the acute and subacute stages
separately from those of people living in the community.
We conducted an investigation of heterogeneity as described in
the Assessment of heterogeneity section above.
Sensitivity analysis
Because of the limited number of included studies, wewere unable
to perform a sensitivity analysis by initially combining low-bias
studies, and then adding in the unclear and high-bias studies to
check for noticeable changes in the results.
For the same reason, we did not conduct a sensitivity analysis to
explore the effect of prospective/retrospective data collectionor the
different forms of data ascertainment described in the Assessment
of risk of bias in included studies section.
As we found studies that comprised single, multiple and multifac-
torial interventions, we conducted a sensitivity analysis by omit-
ting multiple and multifactorial interventions from the pooled
single interventions.
R E S U L T S
Description of studies
Results of the search
We present the study flow diagram of the results of our searches in
Figure 1. Our search strategies identified 5702 records. Removal
of duplicates resulted in 4138 records for initial screening. We
obtained a total of 32 full-text papers for further screening.
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Figure 1. Study flow diagram.
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Included studies
We included 10 studies with a total of 1004 participants. Details
of the included studies can be found in the Characteristics of
included studies table, and are summarised below.
All studies were individually randomised controlled trials. We did
not include any cluster-randomised controlled trials or the first
phase of any cross-over trials.
The included studies enrolled between 34 (Holmgren 2010) and
170 (Green 2002) participants, with a median sample size of 119
participants. Age (mean: standard deviation (SD)) of the partic-
ipants for the experimental and control groups ranged from 57
years (11) (for both groups) in Lau 2012 to 78 years (8) and
79 years (8) respectively in Holmgren 2010. For one study (Lau
2012), the mean age of the participants was under 60 years, two
studies (Dean 2012; Marigold 2005) had a mean age between 60
and 69 years, and in the remaining seven studies, the mean age
was 70 years or older.
The studies were carried out in six different countries: four in
Australia (Batchelor 2012; Dean 2010; Dean 2012; Haran 2010),
two in Japan (Sato 2005a; Sato 2011), and one each in Canada
(Marigold 2005), Hong Kong (Lau 2012), Sweden (Holmgren
2010) and the UK (Green 2002).
All but one study (Dean 2010) recruited participants in the chronic
phase after stroke, with seven studies (Batchelor 2012;Dean 2012;
Green 2002; Haran 2010; Holmgren 2010; Lau 2012; Marigold
2005) recruiting people living in the community and two studies
(Sato 2005a; Sato 2011) being carried out in an institutional or
hospital setting. Dean 2010 recruited participants from an acute
and subacute setting.
All but one study (Sato 2005a) included both men and women.
Sato 2005a included only women who had suffered a stroke.
Five studies (Dean 2010: Dean 2012; Green 2002; Lau 2012;
Marigold 2005) evaluated the effect of exercises on falls. Dean
2010 compared treadmill with overground walking. Dean 2012
investigated theWEBBprogramme involving task-related training
with progressive balance and strengthening exercises as well as
walking and stair climbing in comparison with an exercise class for
the upper limb. Green 2002 compared community physiotherapy
with no intervention. Lau 2012 examined whole-body vibration
in comparisonwith the same exercises without vibration.Marigold
2005 compared agility trainingwith stretching andweight-shifting
exercises.
Two studies investigated the effect of medication on falls; Sato
2005a compared vitaminDwith placebo and Sato 2011 compared
alendronate with alphacalcidol. Haran 2010 examined the effect
of single lens distance vision glasses instead of multifocal glasses,
and this is classified in the ProFaNE taxonomy under Environ-
ment/Assistive technology (aids for communication, information
and signalling). Holmgren 2010 evaluated the effect of a multiple
intervention that largely consisted of individualised and home-
based exercises. Finally, Batchelor 2012 examined the effect of a
multifactorial intervention that also partly consisted of an individ-
ualised home exercise programme but included a comprehensive
risk assessment and referral for a wide range of risk factors. For
further details of the interventions provided, see Characteristics of
included studies.
In one study (Green 2002), the control group did not receive any
intervention. In two studies (Batchelor 2012; Haran 2010), the
control group did not receive an additional treatment (usual care
only). In all other studies, the control group received the same
amount of therapy but another type of treatment, although in the
case of Holmgren 2010 the treatment for the control group was
not dose-matched to that of the intervention group. For further
details of the content of the control group, see the Characteristics
of included studies table.
Excluded studies
From the 32 full-text papers that we screened, we excluded 13
studies (see the Characteristics of excluded studies table). We ex-
cluded most of the studies (nine out of 13) because falls were col-
lected as a measure of an adverse event. These studies, therefore,
although reporting falls, did not have the aim of preventing them.
We excluded Barreca 2004 because the study was not truly ran-
domised, Eng 2010 because it was a narrative review, Halvarsson
2011 because the subgroup of people with stroke consisted of only
four participants, and Mayo 1994 because the author was unable
to provide us with details and data for the stroke subgroup.
Our searching activities did not identify any ongoing trials.
We had insufficient information on four studies, and these await
classification. Prior to publication of the review, we identified one
additional potential study through contact with an expert: this
is also awaiting classification (see the Characteristics of studies
awaiting classification table).
Risk of bias in included studies
For five out of six items of our risk of bias assessment, the majority
of our included studies scored as having low risk of bias. Only
for blinding of outcome assessment (detection bias) did we score
the majority of the included studies as having a high risk of bias.
Details of risk of bias assessment for each study are shown in
the Characteristics of included studies table. Summary results are
shown in Figure 2 and Figure 3.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
We assessed risk of bias for random sequence generation as low
in eight studies (80%) and unclear in the remaining two studies
(20%). We assessed risk of bias for allocation concealment as low
for seven studies (70%) and unclear for the remaining three studies
(30%) (Figure 3).
Blinding
With participant recall or active registration of falls by the par-
ticipant themselves through a falls calendar or diary, we assessed
the risk of bias for blinding as high in eight studies (80%) and as
unclear in two studies (20%) (Figure 3). In the latter two studies
(Sato 2005a; Sato 2011), falls were recorded by nursing staff filling
out standardised fall protocols for institutionalised or hospitalised
people after stroke, but nurses recording falls would also be dis-
pensing medication.
Incomplete outcome data
We scored the risk of bias for incomplete outcome data addressed
as low for eight studies (80%) and high for the remaining two
studies (20%) (Figure 3).
Selective reporting
We assessed reporting bias as low in eight studies (80%) and high
in the remaining two studies (20%) (Figure 3).
Other potential sources of bias
We also assessed whether the falls/fallers outcome was ascertained
reliably. For this item, we scored the risk of bias as low for seven
studies (70%), high for two studies (20%) and unclear for the
remaining study (10%) (Figure 3). The seven studies that scored
low all used a falls calendar that had to be returned monthly with
follow-up telephone calls if necessary. The two studies that scored
high (Dean 2010; Green 2002) used retrospective recall of six
months and three months respectively. We assessed Holmgren
2010 as being at unclear risk because it was not apparent whether
the falls calendar that they used for the six-month follow-up had
to be returned monthly, three-monthly or after six months, and if
there were any follow-up telephone calls.
Effects of interventions
Exercises
Our searches identified five studies that evaluated the effect of
exercises on falls (Dean 2010; Dean 2012; Green 2002; Lau
2012; Marigold 2005). As we also identified one multiple trial
(Holmgren 2010) and one multifactorial trial (Batchelor 2012)
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where the intervention largely consisted of an exercise component,
we decided to include these two studies under the heading ’Exer-
cises’ and combine them with those examining the effect of exer-
cises as a single intervention.
Rate of falls
Data used for this section were based on mean difference reported
in Dean 2010, incidence rate ratio reported in Batchelor 2012
and Dean 2012, and incidence rate ratio calculated by the review
authors in Lau 2012 and Marigold 2005. No data on falls were
obtained from Green 2002 or Holmgren 2010.
Acute/sub-acute stage
The results for falls in Dean 2010 (N = 95) showed that there was
a nonsignificant difference in rate of falls between the intervention
and the control group (rate ratio 0.92, 95% CI 0.45 to 1.90;
Analysis 1.1).
Chronic stage
We pooled the results of four studies (Batchelor 2012; Dean 2012;
Lau 2012; Marigold 2005), including 412 participants (Analysis
1.1), giving a nonsignificant difference in the rate of falls (rate
ratio 0.75, 95%CI 0.41 to 1.38).We were unable to include other
trials that included exercises (Green 2002;Holmgren 2010) in this
analysis due to the lack of group-specific information on falls.
We did not pool results for rate of falls across both stages because
participants in Dean 2010 were hospitalised and in the acute and
subacute phase after stroke, whereas the other trials included com-
munity-dwelling people in the chronic phase after stroke.
When omitting the multifactorial study by Batchelor 2012, our
sensitivity analysis of single interventions resulted in a nonsignif-
icant difference in rate of falls (rate ratio 0.65, 95% CI 0.31 to
1.37).
Number of fallers
Data for this section were based on the risk difference reported by
Dean 2010, the risk ratio reported by Batchelor 2012 and Dean
2012, and the risk ratio calculated by the review authors in Green
2002, Holmgren 2010, Lau 2012 and Marigold 2005.
Acute/sub-acute stage
Dean 2010 (N = 95) indicated that there was a nonsignificant
difference in the number of fallers between the intervention and
control groups (risk ratio 1.19, 95% CI 0.83 to 1.71; Analysis
1.2).
Chronic stage
We pooled the results of six studies (Batchelor 2012; Dean 2012;
Green 2002; Holmgren 2010; Lau 2012; Marigold 2005) with
a total of 616 participants (Analysis 1.2). This demonstrated a
nonsignificant difference in the number of fallers (risk ratio 1.02,
95% CI 0.83 to 1.24).
We decided against pooling results for number of fallers across
both stages after stroke, for the reasons stated above.
When omitting the multiple study by Holmgren 2010 and multi-
factorial study by Batchelor 2012, our sensitivity analysis of single
interventions resulted in a nonsignificant difference in the number
of fallers (risk ratio 1.10, 95% CI 0.86 to 1.41).
Number of people sustaining fall-related fractures
Three studies reported on participants sustaining fall-related frac-
tures. Dean 2012 indicated that one person had a stroke, fractured
his shoulder and died in hospital. Lau 2012 reported that none
of the falls resulted in any injuries that required medical atten-
tion. Finally, one person in the agility group in Marigold 2005
sustained a hip fracture, but on a task that was included in both
programmes.
Number of people with fall-related hospital admissions
Only Lau 2012 indicated that none of the falls resulted in any
injuries that required medical attention.
Number of people with near-fall events
No study that evaluated the effect of exercises reported on the
number of people with near-fall events.
Economic evaluation
No study that investigated the effect of exercises reported an eco-
nomic evaluation.
Quality of life
Every trial reported on quality of life outcomes. Batchelor 2012
used the Falls Efficacy Scale, Swedish modification, but found no
significant result in change scores between groups. Dean 2010 in-
vestigated community participation with the Adelaide Activities
Profile, but found no significant difference between groups. Dean
2012 used the SF-12 version 2 and the Adelaide Activities Pro-
file. No significant results were found for the SF-12, but improve-
ment in the intervention group was noted for the Adelaide Activ-
ities Profile - service to others, and improvement in the control
group was reported for the Adelaide Activities Profile - social ac-
tivities. Green 2002 measured the Frenchay Activities Index, Hos-
pital Anxiety and Depression Scale, and General Health Ques-
tionnaire 28, and found no significant differences between groups
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for any of these measures. Holmgren 2010 used the Falls Efficacy
Scale - international version (FES-I) and the Frenchay Activities
Index. Improvement in the FES-I (compared with baseline) was
significantly greater in the intervention group compared with the
control group post-intervention and at three-month follow-up.
No significant differences were noted for the Frenchay Activities
Index. Holmgren 2010 also reported on the SF-36 and showed
significant improvement (compared with baseline), for the inter-
vention group, for the SF-36 mental dimension and mental health
subscales at three-month follow-up. Both Lau 2012 andMarigold
2005 used the Activities-specific Balance Confidence (ABC) scale
but neither study found a significant between-group difference.
Marigold 2005 also measured the Nottingham Health Profile and
found no difference in outcome between groups.
Adverse events
Two trials reported specifically on adverse events. Dean 2012 indi-
cated that no falls or other adverse events occurred during the ex-
ercise classes, home programme or assessments. Only one partici-
pant withdrew because of the intervention, indicating that the ex-
ercises had exacerbated an incontinence problem. In Lau 2012, no
severe adverse events were reported by the participants, although
three indicated mild dizziness during whole-body vibration ther-
apy, and four had lower-limb soreness and fatigue (two from the
whole-body vibration group). The authors reported that all symp-
toms gradually subsided after the first few sessions of training. As
mentioned above, one person in the agility group in Marigold
2005 sustained a hip fracture, but on a task that was included in
both programmes.
Medication
We present results for this section as originally presented by the
study authors.
Rate of falls
Falls were reported both in Sato 2005a and Sato 2011. Sato 2005a
indicated that of 158 falls during the two-year follow-up, 22 were
in the vitamin D group and 136 in the placebo group. Vitamin
D supplementation accounted for a 59% reduction in falls (95%
CI 28% to 82%, P = 0.003) after adjustments for the covariates.
Sato 2011 reported about 77 falls recorded during the one-year
follow-up period, with 10 falls in the alendronate group and 67
in the alphacalcidol group. After adjustments for the covariates,
alendronate treatment was associated with a 55% reduction in falls
(95% CI 25% to 72%, P = 0.0021).
Number of fallers
Sato 2005a indicated that of 158 falls during the two-year follow-
up period, 11 fallers were in the vitamin D group and 33 in the
placebo group. This accounted for a risk ratio of 0.6 (95% CI 0.4
to 0.8) in favour of vitamin D. Sato 2011 reported that during
the one-year follow-up, five people fell in the alendronate group
and 14 in the alphacalcidol group. This resulted in a relative risk
of 0.7 (95% CI 0.5 to 0.9) in favour of alendronate.
Number of people sustaining fall-related fractures
Sato 2005a reported no hip fractures caused by falls in the vitamin
D group, but four in the placebo group (log rank, P = 0.049).
Sato 2011 indicated that no-one sustained a hip fracture in the
alendronate group, compared with one person in the alphacalcidol
group.
Number of people with fall-related hospital admissions, Number of
people with near-fall events, Economic evaluation, Quality of life,
Adverse events
No study that examined the effect of medication reported on these
outcomes.
Environment/assistive technology
Results for this section, relating to vision improvement, were based
on unpublished data from the stroke subgroup in Haran 2010.
Rate of falls
There was no significant difference in rate of falls when single lens
distance vision glasses replaced multifocal glasses for people after
stroke (rate ratio 1.08, 95% CI 0.52 to 2.25; Analysis 2.1).
Number of fallers
There was no significant difference in the number of fallers when
single lens distance vision glasses replaced multifocal glasses for
people after stroke (risk ratio 0.74, 95% CI 0.47 to 1.18; Analysis
2.2).
Number of people sustaining fall-related fractures
No-one with stroke in the intervention group sustained a fracture,
compared with one person in the control group .
Number of people with fall-related hospital admissions
One person with stroke in the intervention group was admitted
to hospital once, compared with one person with stroke in the
control group admitted to hospital three times.
Number of people with near-fall events
There were no reports of near-fall events.
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Economic evaluation
The data did not allow us to perform an economic evaluation.
Quality of life
Data from the SF-12 physical and mental component score and
Falls Efficacy Scale - International version showed no significant
difference between groups.
Adverse events
There were no reports of adverse events.
D I S C U S S I O N
This review focused on the effects of interventions for preventing
falls in people after stroke, with secondary outcomes examining
the number of people sustaining fall-related fractures, the num-
ber of people with fall-related hospital admissions, the number
of people with near-fall events, economic evaluation, quality of
life (including psychological aspects such as fear of falling), and
adverse events.
Summary of main results
Our search strategies resulted in 10 studies being included in this
review with a total of 1004 participants. Five studies reported an
exercise intervention, two studies the use of medication, one study
an environmental adaptation (providing single lens glasses to users
of multifocal glasses), one study a multiple intervention, and one
study a multifactorial intervention. Since both the multiple and
multifactorial intervention largely consisted of an exercise compo-
nent, both studies were included under ’Exercises’.
Exercises
For rate of falls, results from one study (N = 95) investigating peo-
ple in the acute and subacute stages after stroke, and pooled results
from four studies (N = 412) investigating people in the chronic
stage after stroke did not show a significant reduction in the rate
of falls. For the number of fallers, results from one study (N = 95)
evaluating people in the acute and subacute stages after stroke,
and pooled results from six studies (N = 616) evaluating people in
the chronic stage after stroke also did not show a significant dif-
ference in the number of fallers between both groups. Results for
secondary outcome measures were sparse, with the exception of
quality of life, but because of the heterogeneity of outcome mea-
sures used we decided not to pool these results. Studies assessing
the effect of exercises on preventing falls included a total of 12
measures of quality of life. In three of these measures, a significant
improvement was reported in favour of the intervention group.
Medication
Vitamin D was shown to reduce the rate of falls and the number
of fallers in one study (N = 85) in institutionalised women with
low vitamin D levels in the chronic phase after stroke. In another
study in hospitalised people in the chronic stage after stroke (N =
79), alendronate was also shown to reduce the rate of falls and the
number of fallers. These significant findings should be considered
provisional until data from further studies evaluating these inter-
ventions confirm the results.
Environmental adaptation (vision improvement)
One study assessed the provision of single lens distance vision
glasses instead of multifocal glasses to people after their stroke (N
= 46), and did not show a significant reduction in the rate of falls
nor a difference in the number of fallers between both groups.
Overall completeness and applicability of
evidence
We were only able to include a limited number of trials with a
limited number of participants. In comparison, the review eval-
uating interventions for preventing falls in older people living in
the community (Gillespie 2012) included 159 trials with a total
of 79,193 participants. Even fewer of the trials presented data re-
quired to include them in our analysis of the rate of falls than
in the analysis of the number of fallers. Lamb 2005 provided a
consensus statement that both outcomes should be provided in
trials reporting on interventions evaluating the prevention of falls,
and that future trials should include the numbers of both falls and
fallers when presenting their results.
There is currently insufficient evidence that exercises reduce falling
after stroke. Of interest is the result ofMarigold 2005, which is the
only trial individually demonstrating a significant difference be-
tween an intervention programme of agility exercises with a con-
trol programme that focused on slow and low-impact stretching
and weight-shifting exercises. It should be noted that there is a
difference for the analysis and subsequent result betweenMarigold
2005 and our review. In Marigold 2005, the number of falls and
the number of fallers were analysed with a Mann-Whitney U test
and a Chi² test respectively, and showed no significant between-
group difference. Based on the information fromMarigold 2005,
we were able to calculate the parameters of interest for inclusion
into our meta-analysis (see Analysis 1.1 and Analysis 1.2). Sur-
prisingly, for the rate of falls (see Analysis 1.1), this resulted in a
significant between-group difference in favour of the agility pro-
gramme. For planning future trials, this trial seems to give an im-
portant message about the content of an intervention to prevent
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falls. Furthermore, in the smallest study included in this review
(Holmgren 2010), significant improvements in favour of the in-
tervention group were noted in measures of quality of life, includ-
ing the Falls Efficacy Scale - International version and the SF-36
mental dimension and mental health subscales, even at the three-
month follow-up. For intervention content, which was classified
as multiple, the intervention group performed the high-intensity
functional exercises (HIFE) programme consisting of (1) individ-
ualised exercise sessions including physical activity and functional
performance, aimed at improving lower-limb strength, balance
and gait ability; (2) implementing the functional exercises into
real-life situations; and (3) five one-hour educational sessions with
discussions about the increased risk of complications after stroke,
such as falls. During the last week of intervention, an individu-
alised home-based exercises programmewas designed for each par-
ticipant. Information from this trial might also be important for
planning future trials in this field, but one should remember that
differences in the number of fallers were nonsignificant, although
it should be noted that the power calculation for Holmgren 2010
was not based on preventing falls but on an improvement of the
Berg Balance Scale score.
It should be further noted that some trials reported interesting post
hoc analyses. Marigold 2005 showed that for their participants
with a history of falls, eight out of 15 continued to fall in the inter-
vention group compared with 13 out of 15 in the control group (P
= 0.05). Dean 2012 indicated fewer falls in the intervention group
for their fast walkers but more falls in the intervention group for
their slower walkers. Both studies contribute to the current belief
that interventions should be developed for specific subgroups of
people with stroke. Again, this information can contribute to the
future development of interventions for preventing falls in people
after stroke.
As well as the larger number of studies included in the review
investigating interventions for preventing falls in the elderly liv-
ing in the community (Gillespie 2012), there is another contrast
with our results: multiple-component group exercises, Tai Chi,
and individually prescribed multiple-component home-based ex-
ercises did show a beneficial effect for reducing the rate of falls
and the risk of falling in this population. We should be cautious,
however, considering whether these interventions might be suit-
able for preventing falls in people after stroke. Two recent trials
included in this review (Batchelor 2012; Dean 2012) examined
the effect of an intervention containing an exercise programme
developed for older people: the Otago Exercise Program (OEP) in
Batchelor 2012 and the Weight-bearing Exercise for Better Bal-
ance (WEBB) programme in Dean 2012. Neither trial showed
significant between-group differences for reducing the rate of falls
and the number of fallers, indicating that specific interventions
may be required for preventing falls in people after stroke, with
strategies aimed at particular deficits that people have after their
stroke.
Quality of the evidence
The causes of falls in people after stroke are complex, and a trial
aimed at preventing falls requires a complex intervention. We as-
sessed the majority of trials included in this review as having a low
risk of selection, attrition and reporting biases, as well as a reliable
ascertainment of falls/fallers outcome (see Figure 3). Of concern
was the level of detection bias (blinding of outcome assessment
for falls). In the majority of trials (80%), we assessed this as being
at high risk of bias, as studies used a self reported questionnaire
or a falls calendar or diary. These methods rely on active registra-
tion by the participant, with telephone calls to the participants
if (monthly) fall calendars are not returned. Nevertheless, we as-
sessed this as being at high risk of bias, since the assessors, who
were in this case the participants themselves, were probably not
blinded to group allocation, and because the accuracy of prospec-
tive reportingmethodsmay lead to over- or under-reporting of falls
(Lamb 2005). Kunkel 2011, comparing retrospective interviews
and prospective falls diaries over a 12-month period in a cohort
of 122 people with stroke, found an 83% agreement between the
methods in the classification of fallers. Yet frequent repeat fallers
reported falls during the retrospective interview but did not record
all falls in the diary. Excluding these outliers, a similar number of
falls were reported using either method. Our results for detection
bias and the findings from Kunkel 2011 indicate that monitor-
ing falls accurately in a chronic, community-dwelling population
remains difficult. Although prospective methods are considered
preferable (Hauer 2006), future trials could include both retro-
spective and prospective methods. Nevertheless, preliminary stud-
ies investigating novel assessments of falls, such as portable activity
monitors, seem warranted for future research.
Another concern arising from the trials included in this review
is the definition of falls. Of the 10 trials, only seven provided
a definition of a fall and, among these five different definitions
were used, with two trials (Sato 2005a; Sato 2011) presenting
a definition not referenced to previous literature. Although the
content of these different definitions might not be significantly
different, uniformity should be sought in future trials evaluating
interventions for preventing falls in people after stroke, with a
consensual definition of a fall, such as the one developed by the
Preventions of Falls Network Europe (Lamb 2005).
Finally, for six out of 10 trials, the primary aim was to prevent falls.
For five of the six, a power calculation was also performed based on
establishing a reduction in falls/fallers. The single aimofHolmgren
2010 was to prevent falls, but the power calculation was based
on finding an increase in the Berg Balance Scale score, leading
to a total of 34 participants recruited. The nonsignificant finding
for falls and fallers may have resulted from an inadequate sample
size for this outcome. Unpublished stroke subgroup results from
Haran 2010 should also be interpreted with caution; this analysis
is underpowered, since a limited group of the total study sample
was selected for our analysis. Future trials need to be of adequate
size, with a power calculation based on reasonable estimates of
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effect size, resulting in trials with many more participants. As an
example, Marigold 2005 calculated that, based on their fall data,
a sample size of 292 participants per exercise group would be
required to detect differences for the number of fallers in a future
definitive trial. Future trials will probably need to be multicentred
and perhaps international.
Potential biases in the review process
Although we developed comprehensive search strategies for our
review, there is still a possibility that we have missed some trials.
Nevertheless, as an international group, we are familiar with the
work of colleagues from around the world active in the domain of
falls after stroke, so we were able to include studies reporting on
trials that were only recently completed.
Another potential bias of our review might be that we excluded
trials that reported falls as an adverse event. It could be hypothe-
sised that, although falls were included in these trials despite the
fact that the interventions were not aimed at preventing them,
some of them might actually have a positive effect on falls or the
number of fallers, or both.
Furthermore, one could disagree with our inclusion of Lau 2012
and Marigold 2005 in our pooled analysis, as both arms of these
trials received an active exercise component. We believe that our
decision was justified as, firstly, there is a general mixture of types
of control interventions across our studies, and secondly - and
more importantly - we believe that the experimental interven-
tion in both these studies was focused on significant aspects of
falls prevention. In Lau 2012 the intervention group conducted
whole-body vibration exercises; vibration is thought to improve
muscle weakness, the latter being an important predictor for falls
(Weerdesteyn 2008). Similarly, in Marigold 2005, the aim of the
agility exercises in the experimental group was also clearly more
related to falls prevention than the stretching and slow, low-impact
weight-shifting exercises conducted in the control group.
Finally, although wewere able to obtain data fromone study where
a subgroup of people with stroke was included, we did not use a
systematic approach to obtaining falls data for subgroups of partic-
ipants with a history of stroke in all fall prevention trials. Despite
this, there is strong agreement in identified studies between this
review and Batchelor 2010, who also reviewed interventions for
falls prevention after stroke. It is reassuring that two independent
groups reviewing the same topic largely identify the same studies.
Agreements and disagreements with other
studies or reviews
Our search strategy identified one systematic review on the topic
of falls prevention after stroke. Batchelor 2010 included 13 stud-
ies and their results are in agreement with those of this review.
They also found that the only intervention shown to be effective
in reducing falls was vitamin D for institutionalised women after
stroke with low vitamin D levels (Sato 2005a). However, there is
a discrepancy between the studies included in Batchelor 2010 and
our review. In Batchelor 2010, the type of interventions included
were all those that may affect falls outcome. On that basis, they
also included trials inwhich falls were classified as an adverse event.
Their review therefore contains six trials that we have excluded
from our review, because we applied the stricter inclusion criterion
that interventions had to be aimed at preventing falls. This is an
important distinction. Trials evaluating interventions such as very
earlymobilisation after stroke or early supported discharge include
falls as an outcome. However, the aim of these interventions is
not to prevent falls but to improve functional outcome. Because
(very) early mobilisation or early supported discharge might be as-
sociated with an increase in falls, they are included as an outcome
measure. We believe that a stricter approach, i.e. including only
trials where the aim was to prevent falls, is justified, as otherwise
study hypotheses are mixed and results become difficult to inter-
pret.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Exercises
Currently, there is insufficient evidence that exercises, as a single
component or integrated into a multiple or multifactorial inter-
vention, significantly reduce falling after stroke. There is also in-
sufficient evidence relating to the prevention of fall-related frac-
tures, fall-related hospital admissions, near-fall events, economic
factors, quality of life, or adverse events to inform practice.
Medication
One study showed that vitamin D reduced falling in institution-
alised women in the chronic phase after stroke with low vitamin D
levels. Another study showed that alendronate also reduced falling
in comparison with alphacalcidol in hospitalised people in the
chronic stage after stroke. Both studies need to be replicated be-
fore implementation of these interventions can be used in clinical
practice.
Environmental adaptation (vision improvement)
One study provided people with stroke with single lens distance
vision glasses instead of multifocal glasses, but did not find a sig-
nificant decrease in the rate of falls or the number of fallers.
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Implications for research
This review provides little evidence for the effectiveness of inter-
ventions for preventing falls in people after stroke. Further research
into this important but complex area is warranted.
Further studies are needed to assess exercises as a single compo-
nent or part of a multiple or multifactorial programme, with care-
ful consideration of the content of the intervention, taking into
account the current knowledge about risk factors for falling after
stroke and the possibility that different interventions have to be
developed for different subgroups of people after stroke.
It is important to note that only one study included participants
in the acute and subacute phase. Future research could focus on
the potential of influencing risk factors for falls in people early
after stroke, i.e. while still hospitalised, and on the assessment of
the long-term effect when people are discharged back into their
community.
Further trials assessing medication are needed to confirm previous
findings before recommendations for clinical practice canbemade.
Studies investigating fall prevention for people after stroke should
be adequately powered, provide a standardised definition of a fall
from a consensus statement, use appropriate and accuratemethods
of fall ascertainment, and apply the current standards for analysis
and reporting of data, including the CONSORT guidelines.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Batchelor 2012
Methods A single blind, multicentre RCT with 12-month follow-up
Participants A total of 156 participants were recruited. Participants were people with stroke at risk of
recurrent falls being discharged home from rehabilitation
Interventions In addition to usual care after discharge (physiotherapy and occupational therapy and
follow-upby the generalmedical practitioner), the 12-month study programme consisted
of:
For the intervention group (N = 71): a physiotherapist providing a multifactorial, in-
dividually-tailored falls prevention programme, consisting of: (1) individualised home
exercise programme based on the Otago Exercise Programme; (2) falls risk minimisation
strategies; (3) written and verbal education about falls risk factors and risk minimisation;
(4) injury risk minimisation strategies, and (5) a falls prevention booklet
For the control group (N = 85): a falls prevention booklet
Outcomes Rate of falls, number of fallers, number of people sustaining fall-related fractures, and
quality of life
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “... participants were allocated into
either the control group or the intervention
group (1:1 allocation ration, simple ran-
domization) using a computer-generated
random allocation sequence ...” (page 2)
Allocation concealment (selection bias) Low risk Quote: “... participants were allocated into
either the control group or the interven-
tion group (1:1 allocation ration, simple
randomization) using a computer-gener-
ated random allocation sequence concealed
from all researchers in opaque envelopes.
Staff independent of the study undertook
sequence and concealment.” (page 2)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants recorded falls themselves
through the use of a falls calendar
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Batchelor 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data adequately ad-
dressed and unlikely to seriously alter the
results
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes
have been reported in the prespecified way
Reliable ascertainment of falls/fallers out-
come
Low risk Participants returned the falls calendar each
month. A researcher blinded to group al-
location telephoned participants who did
not return their calendar within 2 weeks of
the due date
Dean 2010
Methods An assessor-blinded RCT
Participants A total of 126 participants unable towalkwithin 4weeks of a stroke whowere undergoing
inpatient rehabilitation
Interventions A conventional stroke rehabilitation programme was provided plus 30 minutes (5 days
a week) of:
For the intervention group (N = 64): walking in a treadmill while supported in a harness.
Once they attained a speed of 0.4 m/s without body-weight support, 10 minutes of the
session was devoted to overground walking
For the control group (N = 62): assisted overground walking (aids allowed). If too dis-
abled, therapy focused on standing, shiftingweight and stepping forwards and backwards
Interventions were provided until participants achieved independent walking or were
discharged from hospital
Outcomes Rate of falls, number of fallers, and quality of life
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The allocation sequence was computer-generated
before commencement of the study and centrally located.”
(page 98)
Allocation concealment (selection bias) Low risk Quote: “After recruitment, the central office was contacted
for allocation so that randomisation was secure and con-
cealed.” (page 98)
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Dean 2010 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Number of falls was quantified by means of a self-reported
questionnaire
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcomedata adequately addressed andunlikely
to seriously alter the results
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes have been reported
in the prespecified way
Reliable ascertainment of falls/fallers out-
come
High risk Fall ascertainment method used was retrospective recall (6-
month period)
Dean 2012
Methods An assessor-blinded RCT
Participants A total of 151 community-dwelling people after stroke
Interventions Both groups participated in exercise classes of 45 to 60 minutes delivered by a physio-
therapist weekly for 40 weeks over a 1-year period consisting of:
For the intervention group (N = 76): an exercise intervention designed to enhance mo-
bility, prevent falls, and increase physical activity - theWEBB programme involving task-
related training with progressive balance and strengthening exercises as well as walking
and stair climbing. The intervention was delivered in a weekly circuit-style group exercise
class and a home exercise programme (to be completed at least 3 times per week), and
advice to increase walking was given
For the control group (N = 75): the exercise class was designed to improve upper limb
function, manage upper limb contracture with task-related strength and co-ordination
training, and improve cognition with matching, sorting and sequencing tasks. The con-
trol group was also prescribed a home programme (to be completed at least 3 times per
week)
Outcomes Rate of falls, number of fallers, quality of life, and adverse events
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The allocation sequence was computer generated
before commencement of the study ...” (page 2)
Allocation concealment (selection bias) Low risk Quote: “... and a set of consecutively numbered, sealed
opaque envelopes containing the allocation was centrally
generated for each stroke club.” (page 2)
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Dean 2012 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants recorded falls themselves through the use of a
falls calendar
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcomedata adequately addressed andunlikely
to seriously alter the results
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes have been reported
in the prespecified way
Reliable ascertainment of falls/fallers out-
come
Low risk Participants returned the falls calendar each month. A re-
searcher telephoned participants who did not return their
calendar
Green 2002
Methods A single-masked RCT
Participants A total of 170patientswithmobility problemsmore than1 year after strokewere included
in the study
Interventions Intervention group (N = 85): physiotherapy treatment by an established community
physiotherapy service as part of their usual work. Patients treated with a problem-solving
approach at home or in outpatient centre. A standard maximum contact period of 13
weeks with a minimum of 3 contacts per patient was agreed
Control group (N = 85): no intervention.
Outcomes Number of fallers and quality of life
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was achieved by numbered, sealed,
opaque envelopes prepared from random number tables ...”
(page 200)
Allocation concealment (selection bias) Low risk Quote: “Randomisation was achieved by numbered, sealed,
opaque envelopes prepared from random number tables ...”
(page 200)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants were asked to recall falls themselves
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Green 2002 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data adequately addressed and unlikely to
seriously alter the results
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes have been reported in
the prespecified way
Reliable ascertainment of falls/fallers out-
come
High risk Fall ascertainment method used was retrospective recall (3-
month period)
Haran 2010
Methods Parallel assessor-blinded RCT
Participants A subgroup of 46 people with stroke (N = 606 for the total group) who were regular
wearers of multifocal glasses and had an increased risk of falls
Interventions Intervention group (N = 22): examination by an optometrist with prescription for a pair
of single lens distance glasses
Control group (N = 24): examination by an optometrist
Outcomes Rate of falls, number of fallers, number of fall-related fractures, and quality of life
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information provided about the sequence
generation process
Allocation concealment (selection bias) Low risk Quote: “... by using sequentially numbered opaque en-
velopes containing group assignment.” (page 2)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants recorded falls themselves through the use
of a falls calendar
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data adequately addressed and un-
likely to seriously alter the results
Selective reporting (reporting bias) Low risk All of the studies’ pre-specified outcomes have been re-
ported in the pre-specified way
Reliable ascertainment of falls/fallers out-
come
Low risk Participants returned the falls calendar eachmonth. Fol-
low-up telephone calls were made as required
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Holmgren 2010
Methods Single-centre, single-blinded RCT
Participants A total of 34 people after stroke with risk of falls were included in the study
Interventions A five-week programme consisting of:
For the intervention group (N = 15): the high-intensity functional exercises (HIFE)
programme consisting of (1) individualised exercise sessions, 45minutes, six times aweek
(30 sessions in a 5-week period) including physical activity and functional performance,
aimed at improving lower-limb strength, balance and gait ability; (2) implementing the
functional exercises into real-life situations (a second 45-minute session); (3) a 1-hour
educational session (1 per week, so 5 in total) with discussions about the increased risk
of complications after stroke, such as falls. During the last week of intervention, an
individualised home-based exercises programme was designed for each participant. The
instruction was to perform this programme 3 times a week at least until the 3-month
follow-up
For the control group (N=19): theymet once aweek for 1hour of educational sessions (so
5 in total), containing group discussions about a variety of topics (e.g. fatigue, depression,
dysphagia, etc) but with no special focus on the risks of falls
Outcomes Number of fallers, quality of life, and adverse events
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization of subjects ... was con-
ducted a minimization software programme ...”
(page 117)
Allocation concealment (selection bias) Unclear risk Method of concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants recorded falls themselves through the
use of a falls calendar
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data adequately addressed
and unlikely to seriously alter the results
Selective reporting (reporting bias) High risk Falls are specified for the total group, but not for
the intervention and control group separately
Reliable ascertainment of falls/fallers out-
come
Unclear risk Unclear whether the falls calendar that was used
throughout the 6-month follow-up had to be re-
turned monthly, 3-monthly or at the end of the 6-
month follow-up
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Lau 2012
Methods RCT
Participants A total of 82 people in the chronic phase after stroke participated in the study
Interventions An 8-week training programme consisting of:
For the intervention group (N = 41): 3 weekly whole-body vibration (WBV) training
sessions. Each session consisted of a 15-minute warm-up in sitting position and 9 to
15 minutes of WBV training. The WBV training comprised dynamic exercises (weight-
shifting, squats, single leg squats, forward lunge). The training volume and intensity
were systematically increased
For the control group (N = 41): they performed the same exercises as the intervention
group while standing on the same platform but with no vibration
Outcomes Rate of falls, number of fallers, number of people sustaining fall-related fractures, number
of people with fall-related hospital admissions, and adverse events
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Low risk Quote: “... using sealed opaque envelopes. To ensure concealed
allocation, the procedures were performed by an ”off-site“ re-
searcher who was not involved in other parts of the study.” (page
1410)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants recorded falls themselves through the use of a log-
book
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data adequately addressed and unlikely to
seriously alter the results
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes have been reported in
the prespecified way
Reliable ascertainment of falls/fallers out-
come
Low risk Falls data were collected by means of a monthly interview until
six months after the end of training
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Marigold 2005
Methods RCT
Participants A total of 61 community-dwelling older adults with chronic stroke
Interventions A 10-week exercise programme (1-hour sessions, 3 times a week) consisting of:
For the intervention (agility) group (N = 30): 5-minute warm-up and 5-minute cool-
down with a programme challenging dynamic balance and emphasising agility and mul-
tisensory approach inbetween. Tasks included standing in various postures, walking with
various challenges, sit-to-stand movement, rapid knee raise in standing and standing
perturbations. Eyes closed conditions and foam surfaces were incorporated for many of
the tasks. The tasks progressively increased in difficulty
For the control (stretching/weight-shifting) group (N = 31): 5-minute warm-up and 5-
minute cool-down with a programme focusing on slow, low-impact movements consist-
ing of stretching and weight shifting inbetween
Outcomes Rate of falls, number of fallers, number of people sustaining fall-related fractures, and
quality of life
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were ... randomly assigned alphanumeric
codes through a random number generator.” (page 417)
Allocation concealment (selection bias) Low risk Quote: “ Subsequently, a person independent of the study (i.e.
concealed allocation) randomly assigned participants ...” (page
417)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants recorded falls themselves through the use of a falls
calendar
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data adequately addressed and unlikely to
seriously alter the results
Selective reporting (reporting bias) High risk A post hoc primary outcome analysis using a subset of data was
performed that was not prespecified
Reliable ascertainment of falls/fallers out-
come
Low risk Participants returned the falls calendar each month for a period
of 1 year. Follow-up telephone calls were made if the monthly
diary was not returned
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Sato 2005a
Methods RCT
Participants A total of 96 hospitalised women in the chronic phase after stroke
Interventions A 2-year study with:
For the intervention group (N = 48): 1000 IU ergocalciferol (vitamin D) daily with
breakfast and dinner
For the control group (N = 48): placebo with breakfast and dinner
Outcomes Rate of falls, number of fallers, and number of people sustaining fall-related fractures
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patients were assigned to one of the two study
groups by means of computer-generated random numbering.”
(page 188)
Allocation concealment (selection bias) Unclear risk Method of concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “Falls were recorded by the nurses who were instructed
to complete the fall protocol ... ” and “... nurses ... were blinded
to the treatment assignment throughout the study.” (page 188)
but nurses recording falls would also be dispensing medication
Incomplete outcome data (attrition bias)
All outcomes
High risk As-treated analysis with numbers of analysis lower compared to
baseline without CONSORT flow chart provided
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes have been reported in
the prespecified way
Reliable ascertainment of falls/fallers out-
come
Low risk Registration by nursing staff by means of fall protocol
Sato 2011
Methods Open-label trial
Participants A total of 82 hospitalised people in the chronic phase after stroke
Interventions A 1-year study with:
For the intervention group (N = 41): a weekly 35 mg dose of alendronate
For the control group (N = 41): a daily 1 µg dose of alphacalcidol
Outcomes Rate of falls, number of fallers, and number of people sustaining fall-related fractures
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Sato 2011 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patients were assigned to 1 of the 2 study groups by
means of computer-generated random numbering.” (page 42)
Allocation concealment (selection bias) Unclear risk Method of concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “Falls were recorded by nurses blinded to the subjects’
information ...” (page 42) but nurses recording falls would also
be dispensing medication
Incomplete outcome data (attrition bias)
All outcomes
High risk As-treated analysis with numbers of analysis lower compared
with baseline without CONSORT flow chart provided
Selective reporting (reporting bias) Low risk All of the studies’ prespecified outcomes have been reported in
the prespecified way
Reliable ascertainment of falls/fallers out-
come
Low risk Registration by nursing staff by means of fall registration
m/s: metres per second
RCT: randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Barreca 2004 No true randomisation of participants
Bernhardt 2008 Falls outcome included as adverse event
Boysen 2009 Falls outcome included as adverse event
Cadilhac 2011 Falls outcome included as adverse event
Duncan 2011 Falls outcome included as adverse event
Eng 2010 Narrative review, not including any new results
Halvarsson 2011 Only 4 people with stroke included in the study (3 in the intervention and 1 in the control group)
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(Continued)
Hesse 2011 Falls outcome included as adverse event
Kong 2009 Falls outcome included as adverse event
Kwok 2005 Falls outcome included as adverse event
Mayo 1994 First author unable to provide details and data for stroke subgroup
Rossi 1990 Falls outcome included as adverse event
Von Koch 2001 Falls outcome included as adverse event
Characteristics of studies awaiting assessment [ordered by study ID]
Cheng 2001
Methods A prospective study where patients were randomly divided into intervention and control groups
Participants 54 patients with hemiplegic stroke (30 in the intervention group, 24 in the control group) admitted to hospital-
based rehabilitation units
Interventions Participants in the control group received conventional stroke rehabilitation
Participants in the intervention group received conventional stroke rehabilitation plus standing postural symmetry
training (through use of a standing biofeedback trainer) and repetitive sit-to-stand training, for 50 minutes, 5 days a
week for 3 weeks
Outcomes Number of fallers
Notes Randomisation unclear. Author contacted to provide necessary details but no response
Rosendahl 2008
Methods RCT with 6-month follow-up period
Participants A total of 191 older people who were dependent in activities of daily living and living in residential care facilities
Interventions Participants were randomly allocated to an intervention group receiving high-intensity functional exercise programme
or a control group, each receiving 29 sessions over a 3-month period
Outcomes Rate of falls and number of fallers
Notes This potentially includable study was identified via contact with an expert
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Sato 2003
Methods A 12-month randomised and prospective study
Participants A chronic stroke sample of 129 in the intervention group and 129 in the control group
Interventions Participants in the intervention group received regular sunlight exposure for 12 months
Participants in the control group (sunlight-deprived) did not receive sunlight exposure
Outcomes Number of falls and fracture incidence
Notes Unclear if primary or secondary aim of intervention was to prevent falls. Author contacted to provide necessary details
but no response
Sato 2005b
Methods An 18-month randomised double-blind trial
Participants A total of 280 males in the subacute stage after stroke: 140 in the intervention group and 140 in the control group
Interventions Participants in the intervention group received a daily dose of 2.5 mg risedronate sodium
Participants in the control group received placebo
Outcomes Number of falls and number of fallers; hip fracture incidence
Notes Unclear if primary or secondary aim of intervention was to prevent falls. Author contacted to provide necessary details
but no response
Sato 2005c
Methods A 12-month, randomised, double-blind, placebo-controlled trial
Participants An acute stroke sample of 187 in the intervention group and 187 in the control group
Interventions Participants in the intervention group received a daily dose of 2.5 mg risedronate for 12 months
Participants in the control group received placebo
Outcomes Number of falls and number of fallers, hip fracture incidence
Notes Unclear if primary or secondary aim of intervention was to prevent falls. Author contacted to provide necessary details
but no response
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D A T A A N D A N A L Y S E S
Comparison 1. Exercise
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Rate of falls 5 Rate Ratio (Random, 95% CI) Subtotals only
1.1 Acute/subacute stage 1 95 Rate Ratio (Random, 95% CI) 0.92 [0.45, 1.90]
1.2 Chronic stage 4 412 Rate Ratio (Random, 95% CI) 0.75 [0.41, 1.38]
2 Number of fallers 7 Risk Ratio (IV, Random, 95% CI) Subtotals only
2.1 Acute/subacute stage 1 95 Risk Ratio (IV, Random, 95% CI) 1.19 [0.83, 1.71]
2.2 Chronic stage 6 616 Risk Ratio (IV, Random, 95% CI) 1.02 [0.83, 1.24]
Comparison 2. Environment: single lens distance glasses versus usual (multifocal) glasses
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Rate of falls 1 43 Rate Ratio (Random, 95% CI) 1.08 [0.52, 2.25]
2 Number of fallers 1 43 Risk Ratio (IV, Random, 95% CI) 0.74 [0.47, 1.18]
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Analysis 1.1. Comparison 1 Exercise, Outcome 1 Rate of falls.
Review: Interventions for preventing falls in people after stroke
Comparison: 1 Exercise
Outcome: 1 Rate of falls
Study or subgroup Exercises Control log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 Acute/subacute stage
Dean 2010 46 49 -0.08 (0.3673) 100.0 % 0.92 [ 0.45, 1.90 ]
Subtotal (95% CI) 100.0 % 0.92 [ 0.45, 1.90 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
2 Chronic stage
Batchelor 2012 60 79 0.0953 (0.2844) 28.8 % 1.10 [ 0.63, 1.92 ]
Dean 2012 76 75 -0.0408 (0.2704) 29.5 % 0.96 [ 0.57, 1.63 ]
Lau 2012 41 41 0 (0.8164) 10.4 % 1.00 [ 0.20, 4.95 ]
Marigold 2005 19 21 -0.9555 (0.2309) 31.4 % 0.38 [ 0.24, 0.60 ]
Subtotal (95% CI) 100.0 % 0.75 [ 0.41, 1.38 ]
Heterogeneity: Tau2 = 0.25; Chi2 = 10.79, df = 3 (P = 0.01); I2 =72%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.18, df = 1 (P = 0.67), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours exercises Favours control
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Analysis 1.2. Comparison 1 Exercise, Outcome 2 Number of fallers.
Review: Interventions for preventing falls in people after stroke
Comparison: 1 Exercise
Outcome: 2 Number of fallers
Study or subgroup Exercises Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Acute/subacute stage
Dean 2010 28/46 25/49 100.0 % 1.19 [ 0.83, 1.71 ]
Subtotal (95% CI) 46 49 100.0 % 1.19 [ 0.83, 1.71 ]
Total events: 28 (Exercises), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
2 Chronic stage
Batchelor 2012 29/60 46/79 28.2 % 0.83 [ 0.60, 1.14 ]
Dean 2012 47/76 38/75 33.6 % 1.22 [ 0.92, 1.62 ]
Green 2002 30/85 23/85 16.3 % 1.30 [ 0.83, 2.05 ]
Holmgren 2010 5/15 6/19 4.0 % 1.06 [ 0.40, 2.80 ]
Lau 2012 3/41 3/41 1.6 % 1.00 [ 0.21, 4.67 ]
Marigold 2005 11/19 16/21 16.3 % 0.76 [ 0.48, 1.19 ]
Subtotal (95% CI) 296 320 100.0 % 1.02 [ 0.83, 1.24 ]
Total events: 125 (Exercises), 132 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 5.88, df = 5 (P = 0.32); I2 =15%
Test for overall effect: Z = 0.15 (P = 0.88)
Test for subgroup differences: Chi2 = 0.60, df = 1 (P = 0.44), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours exercises Favours control
34Interventions for preventing falls in people after stroke (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Environment: single lens distance glasses versus usual (multifocal) glasses,
Outcome 1 Rate of falls.
Review: Interventions for preventing falls in people after stroke
Comparison: 2 Environment: single lens distance glasses versus usual (multifocal) glasses
Outcome: 1 Rate of falls
Study or subgroup Single lens glasses Usual glasses log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Haran 2010 20 23 0.0758 (0.3759) 100.0 % 1.08 [ 0.52, 2.25 ]
Total (95% CI) 100.0 % 1.08 [ 0.52, 2.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours single lens Favours usual glasses
Analysis 2.2. Comparison 2 Environment: single lens distance glasses versus usual (multifocal) glasses,
Outcome 2 Number of fallers.
Review: Interventions for preventing falls in people after stroke
Comparison: 2 Environment: single lens distance glasses versus usual (multifocal) glasses
Outcome: 2 Number of fallers
Study or subgroup Single lens glasses Usual glasses Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Haran 2010 11/20 17/23 100.0 % 0.74 [ 0.47, 1.18 ]
Total (95% CI) 20 23 100.0 % 0.74 [ 0.47, 1.18 ]
Total events: 11 (Single lens glasses), 17 (Usual glasses)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours single lens Favours usual glasses
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
intracranial arterial diseases/ or exp “intracranial embolism and thrombosis”/ or exp intracranial hemorrhages/ or stroke/ or exp brain
infarction/ or vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.
3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$
or hematoma$ or bleed$)).tw.
5. hemiplegia/ or exp paresis/
6. (hemipleg$ or hemipar$ or paresis or paretic).tw.
7. exp gait disorders, neurologic/
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
9. accidental falls/ or accidents/ or exp accident prevention/ or accidents, home/ or accident proneness/
10. (fall or falls or faller or fallen or fallers or falling or fall-related or near-fall or falls-efficacy scale).tw.
11. (slip or slips or slipped or slipping or trip or trips or tripped or tripping).tw.
12. (stumble$ or tumble$).tw
13. (lose adj5 footing).tw.
14. 9 or 10 or 11 or 12 or 13
15. 8 and 14
16. Randomized Controlled Trials as Topic/
17. random allocation/
18. Controlled Clinical Trials as Topic/
19. control groups/
20. clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or
clinical trials, phase iv as topic/
21. double-blind method/
22. single-blind method/
23. Placebos/
24. placebo effect/
25. cross-over studies/
26. Multicenter Studies as Topic/
27. Therapies, Investigational/
28. Research Design/
29. Program Evaluation/
30. evaluation studies as topic/
31. randomised controlled trial.pt.
32. controlled clinical trial.pt.
33. (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.
34. multicenter study.pt.
35. (evaluation studies or comparative study).pt.
36. random$.tw.
37. (controlled adj5 (trial$ or stud$)).tw.
38. (clinical$ adj5 trial$).tw.
39. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
40. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
41. ((multicenter or multicentre or therapeutic) adj5 (trial$ or stud$)).tw.
42. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
43. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
44. (coin adj5 (flip or flipped or toss$)).tw.
45. versus.tw.
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46. (cross-over or cross over or crossover).tw.
47. placebo$.tw.
48. sham.tw.
49. (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline).tw.
50. controls.tw.
51. (treatment$ adj6 order).tw.
52. or/16-51
53. 15 and 52
54. limit 53 to humans
Appendix 2. EMBASE search strategy
1 exp cerebrovascular disease/
2 exp basal ganglion hemorrhage/
3 exp brain ischemia/
4 exp carotid artery disease/
5 exp cerebral artery disease/
6 (intracranial embolism and thrombosis).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword]
7 exp brain hemorrhage/
8 exp brain infarction/
9 exp brain vasospasm/
10 exp artery dissection/
11 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12 (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.
13 ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.
14 ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$
or hematoma$ or bleed$)).tw.
15 hemiplegia/
16 paresis/ Advanced
17 ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$
or hematoma$ or bleed$)).tw.
18 gait disorders, neurologic.mp. or neurologic disease/
19 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20 accident/ or “accidents and accident related phenomena”/ or falling/ or home accident/ or exp accident prevention/ or exp accident
proneness/
21 (fall or falls or faller or fallen or fallers or falling or fall-related or near-fall or falls-efficacy scale).tw.
22 (slip or slips or slipped or slipping or trip or trips or tripped or tripping).tw.
23 (stumble$ or tumble$).tw.
24 (lose adj5 footing).tw.
25 20 or 21 or 22 or 23 or 24
26 19 and 25
27 controlled clinical trial/ or randomized controlled trial/ or “controlled clinical trial (topic)”/
28 randomization/
29 control group/
30 exp clinical trial/ or “clinical trial (topic)”/ or clinical study/ or “controlled clinical trial (topic)”/ or “multicenter study (topic)”/ or
“phase 1 clinical trial (topic)”/ or “phase 2 clinical trial (topic)”/ or “phase 3 clinical trial (topic)”/ or “phase 4 clinical trial (topic)”/
31 double blind procedure/
32 single blind procedure/
33 placebo/
34 palcebo effect.mp.
35 crossover procedure/
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36 “multicenter study (topic)”/
37 experimental therapy/
38 methodology/
39 health care quality/
40 evaluation/
41 randomized controlled trial.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manu-
facturer, drug manufacturer, device trade name, keyword]
42 randomised controlled trial.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manu-
facturer, drug manufacturer, device trade name, keyword]
43 controlled clinical trial.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer,
drug manufacturer, device trade name, keyword]
44 (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).mp. [mp=title, abstract,
subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]
Advanced Display
45 multicenter study.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer,
drug manufacturer, device trade name, keyword]
46 multicentre study.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer,
drug manufacturer, device trade name, keyword]
47 (evaluation studies or comparative study).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword]
48 random$.tw.
49 (controlled adj5 (trial$ or stud$)).tw.
50 (clinical$ adj5 trial$).tw.
51 ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
52 (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
53 ((multicenter or multicentre or therapeutic) adj5 (trial$ or stud$)).tw.
54 ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
55 ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
56 (coin adj5 (flip or flipped or toss$)).tw.
57 versus.tw.
58 (cross-over or cross over or crossover).tw.
59 placebo$.tw.
60 sham.tw.
61 (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline).tw.
62 controls.tw.
63 (treatment$ adj6 order).tw.
64 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or
49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63
65 26 and 64
66 limit 65 to human
Appendix 3. CINAHL search strategy
S1 (MH “Cerebrovascular Disorders”)
S2 (MH “Basal Ganglia Cerebrovascular Disease+”)
S3 (MH “Cerebral Ischemia+”)
S4 (MH “Intracranial Arterial Diseases+”) OR (MH “Intracranial Embolism and Thrombosis+”) OR (MH “Intracranial Hemor-
rhage+”) OR (MH “Stroke+”)
S5 (MH “Carotid Artery Diseases+”)
S6 (MH “Brain Injuries+”)
S7 (MH “Cerebral Vasospasm”)
S8 (MH “Vertebral Artery Dissections”)
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S9 TX (stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc* or cva* or apoplex* or SAH)
S10 TX (brain* or cerebr* or cerebell* or intracran* or intracerebral)
S11 TX (isch?emi* or infarct* or thrombo* or emboli* or occlus*)
S12 S10 AND S11
S13 TX (brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid)
S14 TX (haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed*)
S15 S13 AND S14
S16 (MH “Hemiplegia”)
S17 (MH “Paralysis+”)
S18 TX (hemipleg* or hemipar* or paresis or paretic)
S19 (MH “Gait Disorders, Neurologic+”)
S20 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S12 OR S15 OR S16 OR S17 OR S18 OR S19
S21 (MH “Accidents, Home”) OR (MH “Accidental Falls”) OR (MH “Accidents”)
S22 (MH “Safety”)
S23 TX (fall or falls or faller or fallen or fallers or falling or fall-related or near-fall or falls-efficacy scale)
S24 TX (slip or slips or slipped or slipping or trip or trips or tripped or tripping)
S25 TX (stumble* or tumble*)
S26 TX lose footing
S27 S21 OR S22 OR S23 OR S24 OR S25 OR S26
S28 S20 AND S27
S29 (MH “Randomized Controlled Trials”)
S30 (MH “Random Assignment”)
S31 (MH “Clinical Trials”)
S32 (MH “Control Group”)
S33 (MH “Double-Blind Studies”) OR (MH “Single-Blind Studies”) OR (MH “Triple-Blind Studies”) OR (MH “Intervention Trials”)
OR (MH “Preventive Trials”) OR (MH “Therapeutic Trials”)
S34 (MH “Placebos”) OR (MH “Placebo Effect”)
S35 (MH “Cross Sectional Studies”) OR (MH “Crossover Design”) OR (MH “Multicenter Studies”) OR (MH“Experimental Studies”)
OR (MH “Multimethod Studies”)
S36 (MH “Study Design”) OR (MH “Research Methodology”)
S37 (MH “Program Evaluation”)
S38 (MH “Evaluation Research”)
S39 PT randomised controlled trial
S40 TX randomised controlled trial
S41 PT controlled clinical trial
S42 TX controlled clinical trial
S43 PT (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv)
S44 PT multicenter study
S45 TX multicenter study
S46 PT (evaluation studies or comparative study)
S47 TX (evaluation studies or comparative study)
S48 TX random*
S49 TX controlled
S50 TX (trial* or stud*)
S51 S49 AND S50
S52 TX clinical* trial*
S53 TX (control or treatment or experiment* or intervention)
S54 TX (group* or subject* or patient*)
S55 S53 AND S54
S56 TX (quasi-random* or quasi random* or pseudo-random* or pseudo random*)
S57 TX (multicenter or multicentre or therapeutic)
S58 TX (trial* or stud*)
S59 S57 AND S58
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S60 TX (control or experiment* or conservative)
S61 TX (treatment or therapy or procedure or manage*)
S62 S60 AND S61
S63 TX coin AND TX ( (flip or flipped or toss*) )
S64 TX versus
S65 TX (cross-over or cross over or crossover)
S66 TX placebo*
S67 TX sham*
S68 TX (assign* or alternate or allocat* or counterbalance* or multiple baseline)
S69 TX controls
S70 TX treatment* AND TX order
S71 S52 OR S55 OR S56 OR S59 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
S72 S28 AND S71
S73 S28 AND S71 Limiters - Human
Appendix 4. PsycINFO search strategy
S1 DE “Cerebrovascular Disorders” OR DE “Cerebrovascular Accidents”
S2 DE “Basal Ganglia”
S3 DE “Cerebral Ischemia” OR DE “Cerebral Small Vessel Disease”
S4 DE “Carotid Arteries”
S5 intracranial arterial disease*
S6 “intracranial embolism and thrombosis”
S7 intracranial embolism
S8 DE “Subarachnoid Hemorrhage” OR DE “Cerebral Hemorrhage”
S9 intracranial vasospasm
S10 DE “Brain Disorders”
S11 DE “Cerebral Arteriosclerosis”
S12 TX (stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc* or cva* or apoplex* or SAH)
S13 TX (brain* or cerebr* or cerebell* or intracran* or intracerebral)
S14 TX (brain* or cerebr* or cerebell* or intracran* or intracerebral) AND TX (isch?emi* or infarct* or thrombo* or emboli* or
occlus*)
S15 TX (brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid) AND TX (haemorrhage* or hemorrhage* or
haematoma* or hematoma* or bleed*)
S16 DE “Hemiplegia” OR DE “Hemiparesis”
S17 TX (hemipleg* or hemipar* or paresis or paretic)
S18 TX neurologic gait disorder*
S19 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18
S20 DE “Falls”
S21 DE “Accidents” OR DE “Falls” OR DE “Home Accidents” OR DE “Industrial Accidents” OR DE “Pedestrian Accidents” OR
DE “Transportation Accidents” OR DE “Accident Prevention” OR DE “Home Accidents”
S22 DE “Accident Proneness”
S23 TX (fall or falls or faller or fallen or fallers or falling or fall-related or near-fall or falls-efficacy scale)
S24 TX (slip or slips or slipped or slipping or trip or trips or tripped or tripping)
S25 TX (stumble* or tumble*)
S26 TX lose AND TX footing
S27 S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26
S28 S19 AND S27
S29 DE “Random Sampling”
S30 DE “Clinical Trials”
S31 DE “Experiment Controls”
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S32 DE “Double Bind Interaction”
S33 DE “Placebo”
S34 DE “Experimentation” OR DE “Experimental Methods”
S35 DE “Methodology”
S36 DE “Program Evaluation”
S37 DE “Followup Studies” OR DE “Longitudinal Studies” OR DE “Retrospective Studies”
S38 PT randomised controlled trial
S39 TX randomised controlled trial
S40 PT controlled clinical trial
S41 TX controlled clinical trial
S42 PT (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv)
S43 TX (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv)
S44 PT multicenter study
S45 TX multicenter study Search modes
S46 PT (evaluation studies or comparative study)
S47 TX (evaluation studies or comparative study)
S48 TX random*
S49 TX controlled AND TX (trial* or stud*)
S50 TX clinical* trial*
S51 TX (control or treatment or experiment* or intervention) AND TX (group* or subject* or patient*)
S52 TX (quasi-random* or quasi random* or pseudo-random* or pseudo random*)
S53 TX (multicenter or multicentre or therapeutic) AND TX (trial* or stud*)
S54 TX (control or experiment* or conservative) AND TX (treatment or therapy or procedure or manage*)
S55 TX coin AND TX (flip or flipped or toss*)
S56 TX versus
S57 TX (cross-over or cross over or crossover)
S58 TX placebo*
S59 TX sham
S60 TX (assign* or alternate or allocat* or counterbalance* or multiple baseline)
S61 TX controls
S62 TX treatment* AND TX order
S63 S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43
OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58
OR S59 OR S60 OR S61 OR S62
S64 S28 AND S64
S65 S28 AND S64 Limiters - Population Group: Human
Appendix 5. AMED search strategy
1 Cerebrovascular disorders/
2 exp Basal ganglia/
3 exp Cerebral ischemia/
4 Carotid arteries/
5 intracranial embolism.mp.
6 Brain disease/
7 exp Cerebral infarction/
8 vasospasm.mp.
9 Vertebral artery/
10 Cerebrovascular accident/
11 (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.
12 ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.
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13 ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$
or hematoma$ or bleed$)).tw.
14 Hemiplegia/
15 (hemipleg$ or hemipar$ or paresis or paretic).tw.
16 gait disorders/
17 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18 Accident prevention/ or Accidental falls/
19 accidents/
20 (fall or falls or faller or fallen or fallers or falling or fall-related or near-fall or falls-efficacy scale).tw.
21 (slip or slips or slipped or slipping or trip or trips or tripped or tripping).tw.
22 (stumble$ or tumble$).tw.
23 (lose adj5 footing).tw.
24 18 or 19 or 20 or 21 or 22 or 23
25 17 and 24
26 Randomized controlled trials/
27 Random allocation/
28 controlled clinical trials.mp.
29 control groups.mp.
30 clinical trials/
31 Double blind method/
32 single blind method/
33 Placebos/
34 placebo effect.mp.
35 cross-over studies.mp.
36 multicenter studies.mp.
37 therapies investigational.mp.
38 investigational therapies.mp.
39 Research design/
40 Program evaluation/
41 evaluation studies.mp.
42 randomised controlled trial.pt.
43 controlled clinical trial.pt.
44 (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.
45 multicenter study.pt.
46 (evaluation studies or comparative study).pt.
47 random$.tw.
48 (controlled adj5 (trial$ or stud$)).tw.
49 (clinical$ adj5 trial$).tw.
50 ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
51 (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
52 ((multicenter or multicentre or therapeutic) adj5 (trial$ or stud$)).tw.
53 ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
54 ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
55 (coin adj5 (flip or flipped or toss$)).tw.
56 versus.tw.
57 (cross-over or cross over or crossover).tw.
58 placebo$.tw.
59 sham.tw.
60 (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline).tw.
61 controls.tw.
62 (treatment$ adj6 order).tw.
63 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or
48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62
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C O N T R I B U T I O N S O F A U T H O R S
G Verheyden planned the review, worked with A Ashburn and finalised the planning of the review based on comments from V
Weerdesteyn, R Pickering, D Hyndman, S Lennon and A Geurts.
G Verheyden and V Weerdesteyn independently screened all search results.
G Verheyden, V Weerdesteyn and S Lennon independently screened full-text papers, performed data extraction and risk of bias
screening. A Ashburn also screened all full-text papers for eligibility.
R Pickering and G Verheyden performed data analysis.
G Verheyden wrote the draft of the review and revised the draft based on comments from V Weerdesteyn, R Pickering, D Hyndman,
S Lennon, A Geurts, and A Ashburn.
D E C L A R A T I O N S O F I N T E R E S T
None known
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We decided to pool results for one specific type of intervention (i.e. exercises) from single, multiple and multifactorial interventions.
However, we additionally reported a sensitivity analysis of single interventions only. Thus, trials were not specifically grouped as single,
multiple or multifactorial interventions as specified in our protocol.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Accidental Falls [∗prevention & control; statistics & numerical data]; Alendronate [administration & dosage]; Bone Density Conserva-
tion Agents [administration & dosage]; Exercise; Eyeglasses; Randomized Controlled Trials as Topic; Stroke [∗complications]; Vitamin
D [administration & dosage]; Vitamins [administration & dosage]
MeSH check words
Female; Humans; Male
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